← Eichor
Study identifier: NCT07284966 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comfort and Vision With TOTAL30 Multifocal Lenses

Condition: Myopia · Presbyopia · Astigmatism  ·  Sponsor: Scripps Poway Eyecare and Optometry

PhaseN/A
Planned participants36
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

This study is a single-arm, prospective, observational study conducted at one site to evaluate the comfort and vision of the TOTAL30 Multifocal (T30MF) contact lenses over the course of long wear days. The study will assess the proportion of positive subjective Visual Analog Scale (VAS) assessments of comfort and vision at 10, 12, 14, and 16 hours of wear on Days 1, 7, 14, and 30. Additionally, the study will explore subjective assessments of lens comfort using the CLDEQ-8 survey and measure logMAR visual acuity at both distance and near at Visit 1, Visit 2, and after 1 month of lens wear. Participants will undergo three site visits, with at-home surveys conducted at specified intervals to gather real-time data on comfort and vision.

This description comes directly from the study's public registry record.

Talk to the study team

Leslie Shan  ·  858-530-2800  ·  lshanod@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Scripps Optometric GroupSan Diego, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07284966